• LAST PRICE
    2.7400
  • TODAY'S CHANGE (%)
    Trending Down-0.0900 (-3.1802%)
  • Bid / Lots
    2.6600/ 5
  • Ask / Lots
    2.7800/ 3
  • Open / Previous Close
    2.7700 / 2.8300
  • Day Range
    Low 2.7000
    High 2.8300
  • 52 Week Range
    Low 1.7800
    High 4.6500
  • Volume
    58,346
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 2.83
TimeVolumeNAUT
09:32 ET54942.77
09:33 ET3002.77
10:08 ET10002.8099
10:13 ET2002.75
10:38 ET1002.75
10:51 ET2002.79
11:05 ET1002.8
01:13 ET2002.79
01:15 ET10722.81
01:40 ET21002.83
01:56 ET1002.83
02:03 ET4622.83
02:05 ET1002.79
02:07 ET1002.79
02:14 ET1902.7701
02:16 ET1002.8
02:34 ET1002.76
02:38 ET16002.77
02:39 ET1002.75
02:56 ET1002.75
03:15 ET4722.73
03:33 ET1002.76
03:35 ET1002.71
03:44 ET3002.7
03:46 ET6792.7
03:48 ET5002.7
03:50 ET5002.7
03:51 ET11002.7
03:53 ET16182.705
03:55 ET19892.71
03:57 ET11002.72
04:00 ET13332.74
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesNAUT
Nautilus Biotechnology Inc
353.7M
-5.7x
---
United StatesDNTH
Dianthus Therapeutics Inc
357.1M
-1.6x
---
United StatesINZY
Inozyme Pharma Inc
359.4M
-4.0x
---
United StatesAVIR
Atea Pharmaceuticals Inc
343.8M
-2.8x
---
United StatesAEON
Aeon Biopharma Inc
367.5M
-25.7x
---
United StatesTSHA
Taysha Gene Therapies Inc
357.1M
-0.8x
---
As of 2024-02-20

Company Information

Nautilus Biotechnology, Inc. is a development stage life sciences company. The Company is engaged in creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company is focused on transforming the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its platform end-to-end solution comprised of the proteome analysis system, consumables, and software. The Company’s products include Proteome Analysis System, and Reagent Kits. Its proteome analysis system is a high-resolution optical imaging system coupled with integrated fluidics and liquid handling sub-systems. Its Reagent Kits are comprised of four main components: sample preparation, flow cell(s), multi-affinity probe reagents, and instrument buffers used to perform multi-cycle analysis runs.

Contact Information

Headquarters
2701 Eastlake Ave EastSEATTLE, WA, United States 98102
Phone
206-333-2001
Fax
302-655-5049

Executives

Non-Executive Independent Chairman of the Board
Matthew Posard
President, Chief Executive Officer, Secretary, Director
Sujal Patel
Chief Financial Officer, Treasurer
Anna Mowry
Chief People Officer
Gwen Weld
Senior Vice President - Operations
Mary Godwin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$353.7M
Revenue (TTM)
$0.00
Shares Outstanding
125.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.01
EPS
$-0.48
Book Value
$2.52
P/E Ratio
-5.7x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.